Acute ischemic stroke triggers a cellular senescence-associated secretory phenotype.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
03 08 2021
Historique:
received: 08 02 2021
accepted: 19 07 2021
entrez: 4 8 2021
pubmed: 5 8 2021
medline: 10 11 2021
Statut: epublish

Résumé

Senescent cells are capable of expressing a myriad of inflammatory cytokines and this pro-inflammatory phenomenon is known as senescence-associated secretory phenotype (SASP). The contribution of this phenomenon in brain ischemia was scarce. A mouse model of transient focal cerebral ischemia by compressing the distal middle cerebral artery (tMCAo) for 60 min was used. SASP, pro-inflammatory cytokines and cell cycle mRNAs levels were quantified at 30-min and 72 h post-surgery. Immunohistochemistry in paraffin embedded human brain slides and mouse brain tissue was performed. Our results showed an increase of both p16 and p21 mRNA restricted to the infarct area in the tMCAo brain. Moreover, there was an induction of Il6, Tnfa, Cxc11, and its receptor Cxcr2 mRNA pro-inflammatory cytokines with a high positive correlation with p16/p21 mRNA levels. The p16 was mainly shown in cytoplasm of neurons and cytoplasm/membrane of microglial cells. The p21 was observed in membrane of neurons and also it showed a mixed cytoplasmic and membranous pattern in the microglial cells. In a human stroke patient, an increase of P16 in the perimeter of the MCA infarct area was observed. These suggest a role of SASP in tMCAo mouse model and in human brain tissue. SASP potentially has a physiological role in acute ischemic stroke and neurological function loss.

Identifiants

pubmed: 34344977
doi: 10.1038/s41598-021-95344-5
pii: 10.1038/s41598-021-95344-5
pmc: PMC8333348
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

15752

Informations de copyright

© 2021. The Author(s).

Références

J Am Geriatr Soc. 2016 Oct;64(10):2167-2170
pubmed: 27564081
Nat Neurosci. 2011 Oct 26;14(11):1363-8
pubmed: 22030546
Brain Res Mol Brain Res. 2000 Jun 23;79(1-2):88-101
pubmed: 10925146
Cell. 1997 Mar 7;88(5):593-602
pubmed: 9054499
Trends Pharmacol Sci. 2016 Feb;37(2):101-113
pubmed: 26719217
Nat Rev Dis Primers. 2019 Oct 10;5(1):70
pubmed: 31601801
Aging Cell. 2018 Dec;17(6):e12840
pubmed: 30126037
PLoS Biol. 2018 Jul 3;16(7):e2005970
pubmed: 29969450
Cell Death Dis. 2015 Mar 12;6:e1678
pubmed: 25766317
Nestle Nutr Inst Workshop Ser. 2015;83:11-8
pubmed: 26485647
BMC Vet Res. 2020 Jul 14;16(1):242
pubmed: 32660541
Oncogene. 2012 Nov 15;31(46):4815-27
pubmed: 22310292
Bratisl Lek Listy. 2014;115(11):675-9
pubmed: 25428534
J Clin Invest. 2018 Apr 2;128(4):1238-1246
pubmed: 29608137
J Neurooncol. 2006 May;77(3):273-7
pubmed: 16614947
Neuropathol Appl Neurobiol. 2020 Feb;46(2):171-185
pubmed: 31077599
Metabolites. 2020 May 07;10(5):
pubmed: 32392884
Nat Med. 2015 Dec;21(12):1424-35
pubmed: 26646499
J Biol Chem. 2011 Oct 21;286(42):36396-403
pubmed: 21880712
Nature. 2014 May 22;509(7501):439-46
pubmed: 24848057
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
PLoS Biol. 2008 Dec 2;6(12):2853-68
pubmed: 19053174
Stroke. 2016 Apr;47(4):1068-77
pubmed: 26883501
Genes Dev. 2011 Oct 15;25(20):2125-36
pubmed: 21979375
Mol Neurobiol. 2018 Jul;55(7):6193-6200
pubmed: 29270918
PLoS One. 2019 Mar 11;14(3):e0213673
pubmed: 30856215
Cerebrovasc Dis. 2019;47(3-4):151-164
pubmed: 31055571
Cell Rep. 2018 Jan 23;22(4):930-940
pubmed: 29386135
Angiogenesis. 2004;7(4):323-33
pubmed: 15886876

Auteurs

Coral Torres-Querol (C)

Clinical Neurosciences Group, Institut de Recerca Biomèdica de Lleida (IRBLleida), Lleida, Spain.

Pascual Torres (P)

Experimental Medicine Department, Universitat de Lleida, Institut de Recerca Biomèdica de Lleida (IRBLleida), Lleida, Spain.

Noemí Vidal (N)

Department of Pathology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.

Manel Portero-Otín (M)

Experimental Medicine Department, Universitat de Lleida, Institut de Recerca Biomèdica de Lleida (IRBLleida), Lleida, Spain.

Gloria Arque (G)

Clinical Neurosciences Group, Institut de Recerca Biomèdica de Lleida (IRBLleida), Lleida, Spain.
Experimental Medicine Department, Universitat de Lleida, Institut de Recerca Biomèdica de Lleida (IRBLleida), Lleida, Spain.

Francisco Purroy (F)

Clinical Neurosciences Group, Institut de Recerca Biomèdica de Lleida (IRBLleida), Lleida, Spain. fpurroygarcia@gmail.com.
Stroke Unit, Department of Neurology, Hospital Universitari Arnau de Vilanova, Medicine Department, Clinical Neurosciences Group IRBLleida, Universitat de Lleida, Avda Rovira Roure 80, 25198, Lleida, Spain. fpurroygarcia@gmail.com.
Medicine Department, Universitat de Lleida, Institut de Recerca Biomèdica de Lleida (IRBLleida), Lleida, Spain. fpurroygarcia@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH